Fundz

Medite Cancer Diagnostics, Inc. reported raising $412,000 in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEFeb 09, 2017$411.9K of $3M raised

Amount Raised

$412,000

$412,000 sold, per SEC Form D (first sale Feb 9, 2017)

Round Type

Seed

OrlandoHealthcare

Quick answer

Medite Cancer Diagnostics, Inc. raised $412,000 in a Seed round, dated February 9, 2017. Medite Cancer Diagnostics, Inc. is based in Orlando, Florida, United States.

How much did Medite Cancer Diagnostics, Inc. raise?
Medite Cancer Diagnostics, Inc. raised $412,000 in a Seed round on February 9, 2017.
What does Medite Cancer Diagnostics, Inc. do?
MEDITE® GmbH has grown to be a mid-sized industrial corporation specializing in the development, manufacture and distribution.
Where is Medite Cancer Diagnostics, Inc. based and how big is it?
Medite Cancer Diagnostics, Inc. is based in Orlando, Florida, United States.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Medite Cancer Diagnostics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Lexicon Pharmaceuticals raised $11M on March 24, 2017.
  • MediBeacon raised $11M on March 24, 2017.
  • Bainbridge Health raised $1.3M (Seed) on March 24, 2017.
  • Cardiva Medical, Inc. raised $28M on March 24, 2017.
  • Avalyn raised $17M on March 24, 2017.
  • Active Implants LLC raised $10M on March 24, 2017.

Who to call at Medite Cancer Diagnostics, Inc., and when

A new round usually means Medite Cancer Diagnostics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Medite Cancer Diagnostics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Medite Cancer Diagnostics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Medite Cancer Diagnostics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Medite Cancer Diagnostics, Inc.

Location

4203 SW 34th St

Orlando, Florida, United States

About

MEDITE® GmbH has grown to be a mid-sized industrial corporation specializing in the development, manufacture and distribution.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Medite Cancer Diagnostics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Medite Cancer Diagnostics, Inc.'s next move

See what Strategic adds

Medite Cancer Diagnostics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.